Cancer
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
China’s approval of satri-cel marks a milestone for solid tumor treatment, introducing a targeted cellular therapy for advanced gastric cancer.
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
Phase 1 data show 87% response and 18-month PFS; pivotal phase 2 met goals but BMS withheld numbers as phase 3 begins.
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
The FDA’s August 2026 approval of iberdomide introduces a new class of cancer drugs for patients with relapsed or refractory multiple myeloma.
-
Moderna and Merck’s Personalized Melanoma Vaccine Cuts Recurrence Risk by 42% in Late-Stage Trial
By sequencing individual tumors to target unique neoantigens, Moderna’s platform creates bespoke vaccines in nine weeks, cutting melanoma recurrence risk by 42%.
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
A phase 1 trial of an engineered CD40 antibody published in Cancer Cell found tumor shrinkage in half of 12 patients, with…
-
How Liquid Biopsy Is Transforming Cancer Monitoring and Early Detection Strategies
Non-invasive blood tests are moving beyond niche use to become vital tools for tracking treatment response, detecting recurrence, and screening for cancer.
-
How Texas’ $6B CPRIT Outpaces NIH in Speeding Cancer Breakthroughs
The state’s aggressive funding model recruits top researchers and accelerates treatments—while federal grants face slower bureaucratic hurdles.
-
Zanidatamab’s Dual-Targeting Design Offers Alternative To Trastuzumab Deruxtecan
Zanidatamab’s unique mechanism and clinical data show promise for HER2-positive cancer treatment
-
FDA expands Anktiva approval to cover papillary-only bladder cancer, first treatment for this group
The FDA has broadened Anktiva’s use with BCG to include patients with BCG-unresponsive, high-grade papillary-only non-muscle-invasive bladder cancer, offering a bladder-preserving option…
-
Stanford-Developed Orca-T Wins FDA Approval as First Regulatory T Cell Therapy for Blood Cancer Transplants
STANFORD, October 10 — Stanford Medicine administered the world’s first commercial dose of Orca-T on October 7, 2026, marking the therapy’s debut…
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
WASHINGTON, July 7 — A 13-year gap between a mother’s breast cancer diagnosis and her daughter’s own diagnosis has laid bare persistent…
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
The numbers first: 1,137 patients, split two to one, all with melanoma that surgeons had already removed. On Wednesday, 19 August 2026,…
-
ABC’s Will Reeve Reveals Testicular Cancer Diagnosis and Treatment at His Mother’s Hospital
NEW YORK, September 30 — ABC News correspondent Will Reeve, son of the late Christopher Reeve and Dana Reeve, publicly disclosed his…
-
Immunotherapy Emerges as the Fourth Pillar of Cancer Care, Experts Say
ISLAMABAD, September 20 — Cancer immunotherapy, the approach that harnesses the body’s own immune system to fight tumours, has become the fourth…
-
Doctors Investigate Environmental and Lifestyle Factors Behind Millennial Rectal Cancer Rise
Doctors are asking a hard question about people born after 1980. They want to know what changed. Rectal cancer is rising in…
-
Sydney Girl, 4, Diagnosed With Wilms Tumour After Mother Pushed for Answers
ISLAMABAD, July 3 — A mother’s account of her four-year-old daughter’s diagnosis is offering other parents a sobering look at how easily…
-
Zelig Eshhar’s 1989 CAR Idea and CRISPR Therapeutics’ Off-the-Shelf Zugo-cel Lymphoma Results
BOSTON, July 14 — A new chapter in the fight against cancer is unfolding, and it involves editing a patient’s own immune…
-
Multi-cancer blood tests show early promise, but doctors want proof they work
ROME, July 16 — The shift is happening in plain sight. Cancer detection is moving from single-organ biopsies to a single blood…
-
Indiana Study Links Bowel Cancer Treatment Delays of 47 Days or More to Higher Spread Risk
BLOOMINGTON, July 15 — Researchers at the Indiana University School of Medicine have published a study that cuts through the usual clinical…
-
Colorectal cancer is rising in adults under 50 as many patients are told they are too young
INDIANAPOLIS, July 15 — A study published yesterday by researchers at the Indiana University School of Medicine is bringing new urgency to…
-
ERNA-101 Platform Targets Cancer with Differentiated Therapy
NEW YORK, July 15 — A new targeted cancer therapy platform is moving toward its first human trials, offering a potential advance…
-
Ernexa Plans IND Filing in Q3 and Ovarian Cancer Trial in Q4 2026
NEW YORK, July 15 — Ernexa Therapeutics is moving its lead candidate ERNA-101 toward a first-in-human Phase 1 study, with the trial…
-
Heavy Marijuana Use Linked to Nearly Four Times the Lung Cancer Risk in Large U.S. Study
WASHINGTON, July 15 — A senior epidemiologist at a major U.S. university or government agency is the lead researcher behind a new…
-
Bowel Cancer Five-Year Survival Falls From 91.5% at Early Stage to 16.2% at Stage 4
INDIANAPOLIS, July 15 — A study released yesterday by the Indiana University School of Medicine documents a stark divide in bowel cancer…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992